Application of metabolomics in intrahepatic cholestasis of pregnancy: a systematic review

Background Intrahepatic cholestasis of pregnancy (ICP) is a severe idiopathic disorder of bile metabolism; however, the etiology and pathogenesis of ICP remain unclear. Aims This study comprehensively reviewed metabolomics studies related to ICP, to help in identifying the pathophysiological changes of ICP and evaluating the potential application of metabolomics in its diagnosis. Methods Relevant articles were searched through 2 online databases (PubMed and Web of Science) from January 2000 to March 2022. The metabolites involved were systematically examined and compared. Pathway analysis was conducted through the online software MetaboAnalyst 5.0. Results A total of 14 papers reporting 212 metabolites were included in this study. There were several highly reported metabolites: bile acids, such as glycocholic acid, taurochenodeoxycholic acid, taurocholic acid, tauroursodeoxycholic acid, and glycochenodeoxycholic acid. Dysregulation of metabolic pathways involved bile acid metabolism and lipid metabolism. Metabolites related to lipid metabolism include phosphatidylcholine, phosphorylcholine, phosphatidylserine, sphingomyelin, and ceramide. Conclusions This study provides a systematic review of metabolomics of ICP and deepens our understanding of the etiology of ICP.

Automated summary

This study reviewed metabolomics studies related to intrahepatic cholestasis of pregnancy (ICP), revealing dysregulation of bile acid metabolism and lipid metabolism. Metabolomics shows potential for the diagnosis of ICP.